Proteinuria among renal transplant patients and its relation to hepatitis c virus and graft outcome: A single center experience

Experimental and Clinical Transplantation

Volumn 8, Issue 2, 2010, Pages

  Sabry, Alaa ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Egyptian; HCV; Kidney transplant

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; CYCLOSPORIN; HEPATITIS C ANTIBODY; METHYLPREDNISOLONE; PREDNISONE; PROTEIN; RHEUMATOID FACTOR;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC PYELONEPHRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HEMODIALYSIS; HEPATITIS C; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY AMYLOIDOSIS; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MORTALITY; NEPHRITIS; OBSTRUCTIVE UROPATHY; PREVALENCE; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 77954138570     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Legendre C, Garrigue V, Le Bihan C, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation. 1998;65(5):667-670.
2. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328(7):465-470.
3. Roth D, Cirocco R, Zucker K, et al. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation. 1995;59(12):1676-1682.
4. Baid S, Cosimi AB, Tolkoff-Rubin N, Colvin RB, Williams WW, Pascual M. Renal disease associated with hepatitis C infection after kidney and liver transplantation. Transplantation. 2000;70(2):255-261.
5. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355(9207):887-891.
6. Ghoneim MA, Sobh MA, Shokeir AA, Bakr MA, el-Sherif A, Foda MA. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation. Transplant Proc. 1993;25(3):2243-2245.
7. Fujita Y, Mori I, Kitano S. Determination of proteins by using the color reaction with pyrocatechol violet-molybdenum(VI) complex. Chem Pharm Bull. 1984;32(10):4161-4164.
8. Racusen LC, Solez K, The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55(2):713-723.
9. Cisterne JM, Rostaing L, Izopet J, et al Epidemiology of HCV infection: disease and renal transplantation. Nephrol Dial Transplant. 1996;11(suppl 4):46-47.
10. Hestin D, Guillemin F, Castin N, Le Faou A, Champigneulles J, Kessler M. Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation. Transplantation. 1998;65(5):741-744.
11. Degos F. Natural history of hepatitis C virus infection. Nephrol Dial Transplant. 1996;11(suppl 4):16-18.
12. Sabry AA, Sobh MA, Irving WL, et al. A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant. 2002;17(2):239-245.
13. Legendre C, Garrigue V, Le Bihan C, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation. 1998;65(5):667-670.
14. Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology. 1999;29(1):257-263.
15. First MR, Vaidya PN, Maryniak RK, et al. Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation. 1984;38(6):607-612.
16. Pérez Fontán M, Rodríguez-Carmona A, García Falcón T, Valdés F. Early proteinuria in renal transplant recipients treated with cyclosporin. Transplantation. 1999;67(4):561-568.
17. Roodnat JI, Mulder PG, Rischen-Vos J, et al. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation. 2001;72(3):438-444.
18. Rosenkranz AR, Mayer G. Proteinuria in the transplanted patient. Nephrol Dial Transplant. 2000;15(9):1290-1292.
19. Peddi VR, Dean DE, Hariharan S, Cavallo T, Schroeder TJ, First MR. Proteinuria following renal transplantation: correlation with histopathology and outcome. Transplant Proc. 1997;29(1-2):101-103.
20. Hohage H, Kleyer U, Brückner D, August C, Zidek W, Spieker C. Influence of proteinuria on long-term transplant survival in kidney transplant recipients. Nephron. 1997;75(2):160-165.
21. Pol S, Legendre C, Saltiel C, et al. Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation. J Hepatol. 1992;15(1-2):202-206.
22. Orloff SL, Stempel CA, Wright TL, et al. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection. Clin Transplant. 1995;9(2):119-124.
23. Roth D, Zucker K, Cirocco R, et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int. 1994;45(1):238-244
24. Davis CL, Gretch DR, Perkins JD, et al. Hepatitis C--associated glomerular disease in liver transplant recipients. Liver Transpl Surg. 1995;1(3):166-175.
25. Trendelenburg M, Schifferli JA. Cryoglobulins in chronic hepatitis C virus infection. Clin Exp Immunol. 2003;133(2):275-282.
26. Morales JM. Hepatitis C virus infection and renal disease after renal transplantation. Transplant Proc. 2004;36(3):760-762.